Regular Article
Different Regulation of the Expression of Mouse Hepatic Cytochrome P450 2B Enzymes by Glucocorticoid and Phenobarbital

https://doi.org/10.1006/abbi.1999.1342Get rights and content

Abstract

The effect of the synthetic glucocorticoid, dexamethasone, and phenobarbital upon the expression of Cyp2b9 and Cyp2b10, major CYP2B subfamilies in the mouse, was differentiated in C57BL/6 mouse liver and hepatocytes in primary culture. Overall expression was higher in the untreated female liver than in the male liver. More Cyp2b9 than Cyp2b10 mRNA was present in the female liver, whereas the level of Cyp2b10 was higher in the male. Phenobarbital increased Cyp2b10 expression more than did Cyp2b9 in both sexes. Treatment with dexamethasone markedly induced Cyp2b10 expression dose dependently, but simultaneously suppressed Cyp2b9 in both sexes. Evidence of this was obtained both in vivo and in hepatocyte culture. Furthermore, the existence of at least two unknown species of CYP2B, whose expressions were either increased or decreased by dexamethasone was suggested. Adrenalectomy increased the expression of Cyp2b9 and Cyp2b10 mRNAs, especially that of Cyp2b9 in the male liver. In addition, the expression of one unknown species which was constitutively suppressed increased in adrenalectomized male mice. That the treatment of dexamethasone or adrenalectomy altered the expression of CYP2B subfamilies suggests that endogenous glucocorticoid hormone plays a basic role in the constitutive expression of cytochrome P450. Furthermore, the sex-related difference in the expression of Cyp2b9 and Cyp2b10 suggests that sex-dependent secretion of endogeneous modulating factors is involved in the regulatory pathway.

References (43)

  • G.A. Dannan et al.

    J. Biol. Chem.

    (1986)
  • P. Honkakoski et al.

    Arch. Biochem. Biophys.

    (1989)
  • M. Sharma et al.

    Biochem. Pharmacol.

    (1998)
  • N. Nemoto et al.

    Arch. Biochem. Biophys.

    (1995)
  • T.A. Kocarek et al.

    Biochem. Pharmacol.

    (1994)
  • Y. Yamazoe et al.

    J. Biol. Chem.

    (1987)
  • E.G. Schuetz et al.

    J. Biol. Chem.

    (1990)
  • P. Honkakoski et al.

    J. Biol. Chem.

    (1996)
  • P. Honkakoski et al.

    J. Biol. Chem.

    (1997)
  • C. Stoltz et al.

    J. Biol. Chem.

    (1998)
  • S.A. Kliewer et al.

    Cell

    (1998)
  • N. Nemoto et al.

    Arch. Biochem. Biophys.

    (1995)
  • N. Nemoto et al.

    Biochem. Pharmacol.

    (1992)
  • J. Sakurai et al.

    Biochem. Biophys. Acta

    (1996)
  • T. Omura et al.

    J. Biol. Chem.

    (1964)
  • L. Foucaud et al.

    Biochim. Biophys. Acta

    (1998)
  • D.S. Keeney et al.

    J. Biol. Chem.

    (1998)
  • M. Damon et al.

    Biochem. Biophys. Res. Commun.

    (1996)
  • F.J. Gonzalez et al.

    Pharmacogenetics

    (1993)
  • F.P. Guengerich et al.

    Chem. Res. Toxicol.

    (1991)
  • T.K. Chang et al.

    Drug Metab. Dispos.

    (1997)
  • Cited by (53)

    • Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice

      2012, Fitoterapia
      Citation Excerpt :

      The mice were sacrificed 24 h after the last treatment. Livers were immediately excised for preparing total RNAs as described elsewhere [18]. Mouse OPG, RANKL, and GAPDH mRNAs were semi-quantified by RT-PCR.

    • Modulations of cytochrome P450 expression in diabetic mice by berberine

      2012, Chemico-Biological Interactions
      Citation Excerpt :

      Measurements of lactate dehydrogenase activity in the medium indicated that the treatments were non-toxic at these concentrations. Total RNA was prepared from the cells 24 h later as previously described [18]. Male ddY mice at 6 weeks of age were supplied by Sankyo Experimental Animals, Tokyo, Japan.

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at Department of Toxicology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. Fax: +81-764-34-5046. E-mail: [email protected].

    View full text